Multiple myeloma and chronic lymphocytic leukemia.

Abstract:

:Much progress has been made in delineating the pathogenesis of multiple myeloma and chronic lymphocytic leukemia. The cell of origin in both diseases has been better defined, which has led to important clinical treatments. For myeloma, reduction of tumor burden in autografts has been accomplished and been associated with favorable outcome. The importance of interleukin-6 in maintaining this tumor and causing skeletal disease has been more clearly defined and has led to treatment with antibodies that block this cytokine's action. The bisphosphonate pamidronate decreases skeletal complications and improves quality of life for these patients. For chronic lymphocytic leukemia, further definition of common cytogenetic and gene abnormalities have been made and associated with patient outcome. The nucleoside analogues continue to produce excellent responses and the use of myeloablative chemotherapy with hematopoietic support shows promise in early studies.

journal_name

Curr Opin Hematol

authors

Vescio R,Rosen L,Schmulbach E,Berenson J

doi

10.1097/00062752-199603040-00007

subject

Has Abstract

pub_date

1996-07-01 00:00:00

pages

288-96

issue

4

eissn

1065-6251

issn

1531-7048

journal_volume

3

pub_type

杂志文章,评审
  • Optimal dosing and triggers for prophylactic use of platelet transfusions.

    abstract::Despite the reliance on platelet transfusion support in patients receiving myeloablative therapy, controversies surround platelet transfusion practices. These include the appropriate platelet dose and the threshold at which prophylactic platelet transfusions will be most effective. These issues bear directly on patien...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199911000-00015

    authors: Rinder HM,Arbini AA,Snyder EL

    更新日期:1999-11-01 00:00:00

  • Platelet transfusion support for patients with cancer and hematologic malignancies.

    abstract::Advances in platelet transfusion have contributed to improved outcomes in the treatment of patients with cancer and leukemia. However, the optimal strategies to avoid some of the side effects that could result from platelet transfusions remain under investigation. These side effects include the development of refracto...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199603050-00003

    authors: Sarkodee-Adoo C,Schiffer CA

    更新日期:1996-09-01 00:00:00

  • Lessons from rare maladies: leukocyte adhesion deficiency syndromes.

    abstract:PURPOSE OF REVIEW:The leukocyte adhesion deficiency (LAD) syndromes are rare genetically determined conditions with challenging clinical features. These immunodeficiencies also provide insights that are broadly relevant to the biology of leukocytes, platelets, intercellular interactions, and intracellular signaling. Re...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e32835a0091

    authors: Harris ES,Weyrich AS,Zimmerman GA

    更新日期:2013-01-01 00:00:00

  • The platelet release reaction: just when you thought platelet secretion was simple.

    abstract:PURPOSE OF REVIEW:In response to agonists produced at vascular lesions, platelets release a host of components from their three granules: dense core, alpha, and lysosome. This releasate activates other platelets, promotes wound repair, and initiates inflammatory responses. Although widely accepted, the specific mechani...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e328309ec74

    authors: Ren Q,Ye S,Whiteheart SW

    更新日期:2008-09-01 00:00:00

  • Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia.

    abstract:PURPOSE OF REVIEW:Mutations in the Endoglin (Eng) gene, an auxiliary receptor in the transforming growth factor beta (TGFβ)-superfamily signaling pathway, are responsible for the human vascular disorder hereditary hemorrhagic telangiectasia (HHT) type 1, characterized in part by blood vessel enlargement. A growing body...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000419

    authors: Sugden WW,Siekmann AF

    更新日期:2018-05-01 00:00:00

  • Antimicrobial peptides of leukocytes.

    abstract::Leukocytes use an array of antimicrobial peptides and proteins to help them destroy invading microorganisms. These endogenous antibiotic molecules are remarkable for their structural variety, rapid evolutionary divergence, intraspecies variation, and complex yet subtle interactions with their targets. This arsenal has...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199704010-00009

    authors: Ganz T,Lehrer RI

    更新日期:1997-01-01 00:00:00

  • Monitoring minimal residual disease in patients with chronic myeloid leukemia after treatment with tyrosine kinase inhibitors.

    abstract:PURPOSE OF THE REVIEW:Monitoring for residual leukemic burden is an integral part of ongoing evaluation in chronic myeloid leukemia. With high rates of complete cytogenetic response induced by imatinib and other tyrosine kinase inhibitors, exploring refinements in current methods of minimal residual disease monitoring ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3282f42898

    authors: Sahay T,Schiffer CA

    更新日期:2008-03-01 00:00:00

  • Hematopoietic stem cell lineage specification.

    abstract:PURPOSE OF REVIEW:Hematopoietic stem cells (HSCs) possess two fundamental characteristics, the capacity for self-renewal and the sustained production of all blood cell lineages. The fine balance between HSC expansion and lineage specification is dynamically regulated by the interplay between external and internal stimu...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000260

    authors: Pouzolles M,Oburoglu L,Taylor N,Zimmermann VS

    更新日期:2016-07-01 00:00:00

  • Toll-like receptor signaling and atherosclerosis.

    abstract:PURPOSE OF REVIEW:Chronic inflammation and disordered lipid metabolism represent hallmarks of atherosclerosis. Considerable evidence has accumulated to suggest that innate immune defense mechanisms might interact with proinflammatory pathways and exacerbate or perhaps even initiate development of arterial plaques. Unti...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000219662.88409.7c

    authors: Michelsen KS,Arditi M

    更新日期:2006-05-01 00:00:00

  • Targeting myeloproliferative neoplasms with JAK inhibitors.

    abstract:PURPOSE OF REVIEW:The discovery of JAK2V617F and other JAK-STAT-activating mutations in BCR-ABL1-negative myeloproliferative neoplasms (MPN) has led to the development of small-molecule ATP-mimetics that inhibit wild-type and mutant JAK. Here, we review the current experience with JAK inhibitors used for the treatment ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3283439964

    authors: Pardanani A,Tefferi A

    更新日期:2011-03-01 00:00:00

  • Pathogenesis of chronic immune thrombocytopenic purpura.

    abstract:PURPOSE OF REVIEW:This article summarizes recent insights into the pathophysiology of immune thrombocytopenic purpura, a disorder in which autoantibodies against cell-specific glycoproteins (GPIIb-IIIa, GPIb-IX and others) accelerate platelet destruction. RECENT FINDINGS:Autoantibodies are produced by a limited number...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3282ba5552

    authors: Cines DB,McMillan R

    更新日期:2007-09-01 00:00:00

  • Predicting the risk of recurrence of venous thromboembolism.

    abstract:PURPOSE OF REVIEW:Although several clinical studies have investigated the effects of different treatment periods in subjects after a VTE event, the optimal duration of oral anticoagulation is still uncertain. Our review focused on studies that evaluated different risk factors that might be useful to stratify patients i...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000132310.18883.c0

    authors: Palareti G,Cosmi B

    更新日期:2004-05-01 00:00:00

  • Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitors.

    abstract:PURPOSE OF REVIEW:This review discusses the rationale, efficacy, and toxicity of a variety of immune approaches being evaluated in the therapy of acute myeloid leukemia (AML) including naked and conjugated monoclonal antibodies, bispecific T-cell engager antibodies, and immune checkpoint blockade via antibodies targeti...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000401

    authors: Assi R,Kantarjian H,Ravandi F,Daver N

    更新日期:2018-03-01 00:00:00

  • MicroRNAs in endothelial cell homeostasis and vascular disease.

    abstract:PURPOSE OF REVIEW:Since the first discovery of microRNAs (miRNAs) in 1993, the involvement of miRNAs in different aspects of vascular disease has emerged as an important research field. In this review, we summarize the fundamental roles of miRNAs in controlling endothelial cell functions and their implication with seve...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000424

    authors: Fernández-Hernando C,Suárez Y

    更新日期:2018-05-01 00:00:00

  • Recombinant blood group proteins for use in antibody screening and identification tests.

    abstract:PURPOSE OF REVIEW:The present review elucidates the potentials of recombinant blood group proteins (BGPs) for red blood cell (RBC) antibody detection and identification in pretransfusion testing and the achievements in this field so far. RECENT FINDINGS:Many BGPs have been eukaryotically and prokaryotically expressed ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3283319a06

    authors: Seltsam A,Blasczyk R

    更新日期:2009-11-01 00:00:00

  • Behavioral aspects of neutrophil motility.

    abstract::The ability to move is one of the most basic and critical functions of the neutrophil. The neutrophil changes its shape from round to highly polar and glides along the surface, pausing every 45 to 60 seconds to reestablish its direction. Iterations of this sequence of small-scale motion, or shape change, sum to form t...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199603010-00007

    authors: Coates TD

    更新日期:1996-01-01 00:00:00

  • Problems and prospects in gene therapy for hemophilia.

    abstract::The aim of gene therapy for hemophilia is the stable introduction and expression of a gene encoding functional blood coagulation factor VIII or IX. Although there are as yet no published studies demonstrating long-term expression of therapeutic levels in large animal models of the disease, there have been several repo...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199809000-00003

    authors: Herzog RW,High KA

    更新日期:1998-09-01 00:00:00

  • New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases.

    abstract:PURPOSE OF REVIEW:Intravenous immunoglobulin (IVIg) is an effective treatment for an increasing number of autoimmune and inflammatory conditions. However, IVIg continues to be limited by problems of potential shortages and cost. A number of mechanisms have been described for IVIg, which have been captured in newly emer...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章

    doi:10.1097/MOH.0000000000000609

    authors: Norris PAA,Kaur G,Lazarus AH

    更新日期:2020-11-01 00:00:00

  • Neonatal and pediatric platelet transfusions: current concepts and controversies.

    abstract:PURPOSE OF REVIEW:In this review, we focus on three specific concepts related to platelet transfusion in the neonatal and pediatric population: choice of transfusion threshold; use of ABO-mismatched platelets; transfusion of pathogen-reduced or inactivated platelets. RECENT FINDINGS:Recent trials support the use of lo...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000542

    authors: Patel RM,Josephson C

    更新日期:2019-11-01 00:00:00

  • Hematopoietic stem cells: self-renewal and expansion.

    abstract::: Hematopoietic stem cells (HSCs) are a unique population of cells with the remarkable ability to replenish themselves through self-renewal and to give rise to differentiated cell lineages. Though having been discovered more than 50 years ago, and having been widely used in bone marrow transplantation to treat blood d...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000506

    authors: Li Z,He XC,Li L

    更新日期:2019-07-01 00:00:00

  • Biologic functions of blood group antigens.

    abstract::In the past few years, we have learned a great deal about the biologic function of structures bearing blood group antigens. Some blood group antigen-bearing proteins function as major transport channels within the erythrocyte membrane; these include the anion transporter (band 3: Diego and Wright antigens), the water ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199603060-00013

    authors: Mudad R,Telen MJ

    更新日期:1996-11-01 00:00:00

  • Coagulation inhibition for sepsis.

    abstract::Following on the heels of multiple failed clinical trials of adjunctive therapeutic agents in sepsis, the positive outcome of a recent phase III study using activated protein C (APC) has led to a renewed optimism in targeted biotherapies for this syndrome. A growing body of data (both preclinical and clinical) suggest...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200209000-00005

    authors: Key NS,Ely EW

    更新日期:2002-09-01 00:00:00

  • The role of PI3K/protein kinase B (PKB/c-akt) in migration and homing of hematopoietic stem and progenitor cells.

    abstract:PURPOSE OF REVIEW:Hematopoietic stem cell (HSC) transplantation is the most powerful treatment modality for a variety of hematological disorders. Successful hematopoietic recovery after transplantation depends on optimal homing of HSCs to the bone marrow and subsequent lodging in the HSC niche. The molecular mechanisms...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e32834760e5

    authors: Buitenhuis M

    更新日期:2011-07-01 00:00:00

  • Novel strategies for steroid-refractory acute graft-versus-host disease.

    abstract:PURPOSE OF REVIEW:Graft-versus-host disease is one of the commonest complications of allogeneic bone marrow or peripheral blood stem cell transplantation. This review will cover advances in the pathophysiology of graft-versus-host disease and new agents under investigation for the treatment of this disorder. Patients d...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000148763.12733.bb

    authors: Bolaños-Meade J,Vogelsang GB

    更新日期:2005-01-01 00:00:00

  • 'Waterloo': when normal blood cells meet leukemia.

    abstract:PURPOSE OF REVIEW:Mortality and morbidity associated with leukemia are largely due to frequently occurring cytopenias or the dysfunction of normal blood cells in patients. Our knowledge of how normal blood cells degenerate in response to leukemic cell infiltration has been quite limited. This review summarizes recent f...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000253

    authors: Cheng H,Cheng T

    更新日期:2016-07-01 00:00:00

  • Transcriptional control of erythropoiesis.

    abstract::Over the past year, substantial progress was made toward understanding transcriptional control of red cell differentiation. Complementary DNAs encoding two novel erythroid-restricted transcription factors--globin locus control region regulatory factor NF-E2 and CACC-binding protein EKLF--were cloned and characterized....

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:

    authors: Andrews NC,Orkin SH

    更新日期:1994-03-01 00:00:00

  • Zinc-finger transcription factor Gfi-1: versatile regulator of lymphocytes, neutrophils and hematopoietic stem cells.

    abstract:PURPOSE OF REVIEW:Gfi-1, originally identified as a transcriptional repressor in lymphoid cells, is now recognized to have essential, independent functions in neutrophil maturation and hematopoietic stem cell biology. Here we review recent studies pertaining to Gfi-1 and its cell context specific functions in hematopoi...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000190111.85284.8f

    authors: Hock H,Orkin SH

    更新日期:2006-01-01 00:00:00

  • Clonal diversity of the stem cell compartment.

    abstract:PURPOSE OF REVIEW:Hematopoietic stem cells are functionally heterogeneous even when isolated as phenotypically homogenous populations. How this heterogeneity is generated is incompletely understood. Several models have been formulated to explain the generation of diversity. All of these assume the existence of a single...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000231421.00407.65

    authors: Muller-Sieburg CE,Sieburg HB

    更新日期:2006-07-01 00:00:00

  • Fibroblast growth factor signaling promotes physiological bone remodeling and stem cell self-renewal.

    abstract:PURPOSE OF REVIEW:Fibroblast growth factor (FGF) signaling activates many bone marrow cell types, including various stem cells, osteoblasts, and osteoclasts. However, the role of FGF signaling in regulation of normal and leukemic stem cells is poorly understood. This review highlights the physiological roles of FGF sig...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3283606162

    authors: Itkin T,Kaufmann KB,Gur-Cohen S,Ludin A,Lapidot T

    更新日期:2013-05-01 00:00:00

  • Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models.

    abstract::Several methods to model human Ph+ leukemia in laboratory mice are available, including propagation of BCR/ABL-expressing cells in mice, xenotransplantation of primary Ph+ leukemia cells into immunodeficient mice, BCR/ABL transgenic mice, and BCR/ABL retroviral bone marrow transduction and transplantation. Recent stud...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200107000-00008

    authors: Van Etten RA

    更新日期:2001-07-01 00:00:00